Refresh

Mavens Biotech Ltd. - Research Center

590083 MAVENSBIO Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12
Income

Operating income

0.83 1.06 38.18 45.83 45.56
Expenses

Material consumed

- - 37.40 44.19 43.68

Manufacturing expenses

- - 0.01 0.01 -

Personnel expenses

0.22 0.24 0.21 0.24 0.25

Selling expenses

- - - - -

Adminstrative expenses

0.34 0.49 0.37 0.46 0.55

Expenses capitalised

- - - - -

Cost of sales

0.56 0.73 37.99 44.90 44.49

Operating profit

0.27 0.33 0.19 0.93 1.07

Other recurring income

- 0.08 0.11 0.09 0.11

Adjusted PBDIT

0.27 0.40 0.29 1.03 1.18

Financial expenses

- - - - -

Depreciation

0.15 0.28 0.22 0.28 0.37

Other write offs

- - - - -

Adjusted PBT

0.12 0.13 0.07 0.75 0.81

Tax charges

0.04 - 0.01 - 0.10

Adjusted PAT

0.08 0.13 0.07 0.75 0.70

Non recurring items

- - - -0.04 -

Other non cash adjustments

- - - - -

Reported net profit

0.08 0.13 0.07 0.71 0.70

Earnigs before appropriation

6.05 5.86 5.84 5.77 5.06

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

6.05 5.86 5.84 5.77 5.06
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com